Pediatric demyelinating disease and anti‐MOG antibody

Significant progress has been made in the field of pediatric neuroimmunology over the past few years. With the detection of conformationally correct myelin oligodendrocyte glycoprotein (MOG) antibodies using cell‐based assays, children with different monophasic and relapsing phenotypes have been increasingly described. However, there is still controversy regarding the severity of the disease course and outcome of this emerging and rapidly...